Pacific Biosciences Of California | PACB - Net Income


Pacific Biosciences Of California reported $-40.37M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Bruker USD 3.5M 22.5M Mar/2026
Danaher USD 870M 159M Jun/2026
General Electric Aerospace USD 2.37B 466M Jun/2026
Illumina USD 207M 73M Jun/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quidel USD -91.8M 38.9M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Standard Biotools USD 127.07M 107.78M Mar/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Waters USD -72M 297.21M Mar/2026